You are here

  • Home
  • Archive
  • Volume 29, Issue 3
  • Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

Article info

Article menu
Download PDFPDF
PostScript
Letter
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

Authors

  1. Correspondence to Dr Andrea Messori, HTA Unit, Regione Toscana, Via Alderotti 26/N, 50135 Firenze, Italy; andrea.messori.it{at}gmail.com
View Full Text

Citation

Messori A, Bartoli L, Mengato D, et al
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available
European Journal of Hospital Pharmacy 2022;29:e1.

Publication history

  • First published November 30, 2020.
Online issue publication 
April 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.